RapidAI builds FDA-cleared clinical AI software that reads CT, CTA, CT perfusion and MRI scans to flag stroke, aneurysms and pulmonary embolisms in minutes - giving hospital teams a faster path to treatment. The platform began life as the Stanford spin-out iSchemaView and now runs in more than 2,000 hospitals across 100+ countries.

Adam Elsesser is the co-founder, Chairman and CEO of Penumbra, the Alameda-based medical device company that pioneered aspiration thrombectomy for stroke. A former real estate lawyer turned operator, he has run Penumbra since 2004 and, in January 2026, agreed to sell it to Boston Scientific for roughly $14.5 billion.